Ischemic cardiovascular disease in persons with human immunodeficiency virus infection

Clinical Infectious Diseases

Volumn 34, Issue 1, 2002, Pages 98-102

  David, Max H ^a,c   Hornung, Richard ^b   Fichtenbaum, Carl J ^a  

^a Division of Infectious Diseases   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c SAINT LOUIS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HEART INFARCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFECTION RISK; LYMPHOCYTE COUNT; MALE; MEDICAL RECORD; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES;

ADULT; AGED; CARDIOVASCULAR DISEASES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; RISK FACTORS; SMOKING;

EID: 0036133520     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/324745     Document Type: Article

References (14)

1. Primary prevention of coronary artery disease: Guidance from Framingham: A statement for healthcare professionals from the AHA Task Force on Risk Reduction
2. Cardiac complications of acquired immune deficiency syndrome (AIDS): A review
3. Myocarditis and cardiotropic viral infection associated with severe left ventricular dysfunction in late- stage infection with human immunodeficiency virus
4. HIV-related cardiovascular disease
5. Severe premature coronary artery disease with protease inhibitors
6. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy
7. Do protease inhibitors increase the risk for coronary heart disease among HIV-positive patients?
8. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: A cohort study
9. Hyperlipidemia under treatment with proteinase inhibitors
10. HIV protease inhibitors: Advances in therapy and adverse reactions, including metabolic complications
11. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance
12. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors
13. Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
14. Ischemic heart disease